1. Academic Validation
  2. The one-carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation

The one-carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation

  • Mol Oncol. 2024 Mar 27. doi: 10.1002/1878-0261.13645.
Petra Marttila 1 Nadilly Bonagas 1 Christina Chalkiadaki 1 Hannah Stigsdotter 1 Korbinian Schelzig 1 Jianyu Shen 1 Crystal M Farhat 1 Amber Hondema 1 Julian Albers 1 Elisée Wiita 1 Azita Rasti 1 Ulrika Warpman Berglund 1 Ana Slipicevic 1 2 Oliver Mortusewicz 1 Thomas Helleday 1 3
Affiliations

Affiliations

  • 1 Science for Life Laboratory, Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.
  • 2 One-carbon Therapeutics AB, Stockholm, Sweden.
  • 3 Weston Park Cancer Centre, Department of Oncology and Metabolism, The Medical School, University of Sheffield, UK.
Abstract

The one-carbon metabolism Enzyme bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2 (MTHFD2) is among the most overexpressed proteins across tumors and is widely recognized as a promising Anticancer target. While MTHFD2 is mainly described as a mitochondrial protein, a new nuclear function is emerging. Here, we observe that nuclear MTHFD2 protein levels and association with chromatin increase following ionizing radiation (IR) in an ataxia telangiectasia mutated (ATM)- and DNA-dependent protein kinase (DNA-PK)-dependent manner. Furthermore, repair of IR-induced DNA double-strand breaks (DSBs) is delayed upon MTHFD2 knockdown, suggesting a role for MTHFD2 in DSB repair. In support of this, we observe impaired recruitment of replication protein A (RPA), reduced resection, decreased IR-induced DNA repair protein RAD51 homolog 1 (RAD51) levels and impaired homologous recombination (HR) activity in MTHFD2-depleted cells following IR. In conclusion, we identify a key role for MTHFD2 in HR repair and describe an interdependency between MTHFD2 and HR proficiency that could potentially be exploited for Cancer therapy.

Keywords

DSB repair; MTHFD2; homologous recombination; ionizing radiation.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-14731
    99.67%, ATR Inhibitor